|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
4
|
Bardeesy N and DePinho RA: Pancreatic
cancer biology and genetics. Nat Rev Cancer. 2:897–909. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Muniraj T, Jamidar PA and Aslanian HR:
Pancreatic cancer: A comprehensive review and update. Dis Mon.
59:368–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakai T, Toguchida J, Ohtani N, Yandell
DW, Rapaport JM and Dryja TP: Allele-specific hypermethylation of
the retinoblastoma tumor-suppressor gene. Am J Hum Genet.
48:880–888. 1991.PubMed/NCBI
|
|
7
|
Esteller M: CpG island hypermethylation
and tumor suppressor genes: A booming present, a brighter future.
Oncogene. 21:5427–5440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kirchhoff C, Habben I, Ivell R and Krull
N: A major human epididymis-specific cDNA encodes a protein with
sequence homology to extracellular proteinase inhibitors. Biol
Reprod. 45:350–357. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clauss A, Lilja H and Lundwall A: A locus
on human chromosome 20 contains several genes expressing protease
inhibitor domains with homology to whey acidic protein. Biochem J.
368:233–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bingle CD: Towards defining the complement
of mammalian WFDC-domain-containing proteins. Biochem Soc Trans.
39:1393–1397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Galgano MT, Hampton GM and Frierson HF Jr:
Comprehensive analysis of HE4 expression in normal and malignant
human tissues. Mod Pathol. 19:847–853. 2006.PubMed/NCBI
|
|
12
|
Jiang SW, Chen H, Dowdy S, Fu A, Attewell
J, Kalogera E, Drapkin R, Podratz K, Broaddus R and Li J: HE4
transcription- and splice variants-specific expression in
endometrial cancer and correlation with patient survival. Int J Mol
Sci. 14:22655–22677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Drapkin R, von Horsten HH, Lin Y, Mok SC,
Crum CP, Welch WR and Hecht JL: Human epididymis protein 4 (HE4) is
a secreted glycoprotein that is overexpressed by serous and
endometrioid ovarian carcinomas. Cancer Res. 65:2162–2169. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ryu B, Jones J, Blades NJ, Parmigiani G,
Hollingsworth MA, Hruban RH and Kern SE: Relationships and
differentially expressed genes among pancreatic cancers examined by
large-scale serial analysis of gene expression. Cancer Res.
62:819–826. 2002.PubMed/NCBI
|
|
15
|
Huang T, Jiang SW, Qin L, Senkowski C,
Lyle C, Terry K, Brower S, Chen H, Glasgow W, Wei Y, et al:
Expression and diagnostic value of HE4 in pancreatic
adenocarcinoma. Int J Mol Sci. 16:2956–2970. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Neal RL, Nam KT, LaFleur BJ, Barlow B,
Nozaki K, Lee HJ, Kim WH, Yang HK, Shi C, Maitra A, et al: Human
epididymis protein 4 is up-regulated in gastric and pancreatic
adenocarcinomas. Hum Pathol. 44:734–742. 2013. View Article : Google Scholar
|
|
17
|
Angioli R, Miranda A, Aloisi A, Montera R,
Capriglione S, De Cicco Nardone C, Terranova C and Plotti F: A
critical review on HE4 performance in endometrial cancer: Where are
we now? Tumour Biol. 35:881–887. 2014. View Article : Google Scholar
|
|
18
|
Moore RG, Miller CM, Brown AK, Robison K,
Steinhoff M and Lambert-Messerlian G: Utility of tumor marker HE4
to predict depth of myometrial invasion in endometrioid
adenocarcinoma of the uterus. Int J Gynecol Cancer. 21:1185–1190.
2011.PubMed/NCBI
|
|
19
|
Faca VM, Song KS, Wang H, Zhang Q,
Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS,
Pitteri SJ, et al: A mouse to human search for plasma proteome
changes associated with pancreatic tumor development. PLoS Med.
5:e1232008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brand RE, Nolen BM, Zeh HJ, Allen PJ,
Eloubeidi MA, Goldberg M, Elton E, Arnoletti JP, Christein JD,
Vickers SM, et al: Serum biomarker panels for the detection of
pancreatic cancer. Clin Cancer Res. 17:805–816. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bingle CD and Vyakarnam A: Novel innate
immune functions of the whey acidic protein family. Trends Immunol.
29:444–453. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scott A, Weldon S and Taggart CC: SLPI and
elafin: Multifunctional antiproteases of the WFDC family. Biochem
Soc Trans. 39:1437–1440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chhikara N, Saraswat M, Tomar AK, Dey S,
Singh S and Yadav S: Human epididymis protein-4 (HE-4): A novel
cross-class protease inhibitor. PLoS One. 7:e476722012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
LeBleu VS, Teng Y, O'Connell JT, Charytan
D, Müller GA, Müller CA, Sugimoto H and Kalluri R: Identification
of human epididymis protein-4 as a fibroblast-derived mediator of
fibrosis. Nat Med. 19:227–231. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hua L, Liu Y, Zhen S, Wan D, Cao J and Gao
X: Expression and biochemical characterization of recombinant human
epididymis protein 4. Protein Expr Purif. 102:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bignotti E, Ragnoli M, Zanotti L, Calza S,
Falchetti M, Lonardi S, Bergamelli S, Bandiera E, Tassi RA, Romani
C, et al: Diagnostic and prognostic impact of serum HE4 detection
in endometrial carcinoma patients. Br J Cancer. 104:1418–1425.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kalogera E, Scholler N, Powless C, Weaver
A, Drapkin R, Li J, Jiang SW, Podratz K, Urban N and Dowdy SC:
Correlation of serum HE4 with tumor size and myometrial invasion in
endometrial cancer. Gynecol Oncol. 124:270–275. 2012. View Article : Google Scholar
|
|
28
|
Zanotti L, Bignotti E, Calza S, Bandiera
E, Ruggeri G, Galli C, Tognon G, Ragnoli M, Romani C, Tassi RA, et
al: Human epididymis protein 4 as a serum marker for diagnosis of
endometrial carcinoma and prediction of clinical outcome. Clin Chem
Lab Med. 50:2189–2198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Angioli R, Plotti F, Capriglione S,
Montera R, Damiani P, Ricciardi R, Aloisi A, Luvero D, Cafà EV,
Dugo N, et al: The role of novel biomarker HE4 in endometrial
cancer: A case control prospective study. Tumour Biol. 34:571–576.
2013. View Article : Google Scholar
|
|
30
|
Lu R, Sun X, Xiao R, Zhou L and Gaoxand
Guo L: Human epididymis protein 4 (HE4) plays a key role in ovarian
cancer cell adhesion and motility. Biochem Biophys Res Commun.
419:274–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Chen H, Mariani A, Chen D, Klatt E,
Podratz K, Drapkin R, Broaddus R, Dowdy S and Jiang SW: HE4 (WFDC2)
promotes tumor growth in endometrial cancer cell lines. Int J Mol
Sci. 14:6026–6043. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu YF, Gao GL, Tang SB, Zhang ZD and
Huang QS: Effect of WFDC 2 silencing on the proliferation, motility
and invasion of human serous ovarian cancer cells in vitro. Asian
Pac J Trop Med. 6:265–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Y, Mu X, Wang S, Zhao L, Wu Y, Li J
and Li M: WAP four-disulfide core domain protein 2 mediates the
proliferation of human ovarian cancer cells through the regulation
of growth-and apoptosis-associated genes. Oncol Rep. 29:288–296.
2013.
|
|
34
|
Wang H, Zhu L, Gao J, Hu Z and Lin B:
Promotive role of recombinant HE4 protein in proliferation and
carboplatin resistance in ovarian cancer cells. Oncol Rep.
33:403–412. 2015.
|
|
35
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ahrendt SA and Pitt HA: Surgical
management of pancreatic cancer. Oncology. 16:725–743.
2002.PubMed/NCBI
|
|
37
|
Missiaglia E, Blaveri E, Terris B, Wang
YH, Costello E, Neoptolemos JP, Crnogorac-Jurcevic T and Lemoine
NR: Analysis of gene expression in cancer cell lines identifies
candidate markers for pancreatic tumorigenesis and metastasis. Int
J Cancer. 112:100–112. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hamilton CA, Cheung MK, Osann K, Chen L,
Teng NN, Longacre TA, Powell MA, Hendrickson MR, Kapp DS and Chan
JK: Uterine papillary serous and clear cell carcinomas predict for
poorer survival compared to grade 3 endometrioid corpus cancers. Br
J Cancer. 94:642–646. 2006.PubMed/NCBI
|
|
39
|
Zou SL, Chang XH, Ye X, Cheng HY, Cheng
YX, Tang ZJ, Zhang ZJ, Gao L, Chen XH and Cui H: Effect of human
epididymis protein 4 gene silencing on the malignant phenotype in
ovarian cancer. Chin Med J. 124:3133–3140. 2011.PubMed/NCBI
|
|
40
|
Moore RG, Hill EK, Horan T, Yano N, Kim K,
MacLaughlan S, Lambert-Messerlian G, Tseng YD, Padbury JF, Miller
MC, et al: HE4 (WFDC2) gene overexpression promotes ovarian tumor
growth. Sci Rep. 4:35742014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kelman Z: PCNA: Structure, functions and
interactions. Oncogene. 14:629–640. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Moldovan GL, Pfander B and Jentsch S: PCNA
controls establishment of sister chromatid cohesion during S phase.
Mol Cell. 23:723–732. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiong Y, Hannon GJ, Zhang H, Casso D,
Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin
kinases. Nature. 366:701–704. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Waga S, Hannon GJ, Beach D and Stillman B:
The p21 inhibitor of cyclin-dependent kinases controls DNA
replication by interaction with PCNA. Nature. 369:574–578. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen J, Jackson PK, Kirschner MW and Dutta
A: Separate domains of p21 involved in the inhibition of Cdk kinase
and PCNA. Nature. 374:386–388. 1995. View Article : Google Scholar : PubMed/NCBI
|
